Melanocyte-stimulating hormone release inhibiting factor

Name Melanocyte-stimulating hormone release inhibiting factor
Supplier Tocris Bioscience
Catalog 2243
Prices $75.00
Sizes 10 mg
Function Type Inhibitor
Cas Number 2002-44-0
Formula C13H24N4O3
Molecular Weight 284.36
Description Inhibitor of melanocyte-stimulating hormone (MSH) release. Blocks the release of α -MSH, increases brain dopamine levels and antagonizes physiological and behavioral opioid effects in vivo .
Supplier Page Shop

Product References

Pharmacological studies with a tripeptide, prolyl-leucyl glycine amide. - Pharmacological studies with a tripeptide, prolyl-leucyl glycine amide.

Plotnikoff NP, Kastin AJ. Arch Int Pharmacodyn Ther. 1974 Oct;211(2):211-24.

Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part - Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part

Pugsley TA, Lippmann W. Arzneimittelforschung. 1977;27(12):2293-6.

Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review. - Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.

Mishra RK, Chiu S, Chiu P, Mishra CP. Methods Find Exp Clin Pharmacol. 1983;5(4):203-33.

Inhibitory influences of FMRFamide and PLG on stress-induced opioid analgesia and - Inhibitory influences of FMRFamide and PLG on stress-induced opioid analgesia and

Kavaliers M, Hirst M. Brain Res. 1986 May 7;372(2):370-4.